PatientsVille.com LogoPatientsVille.com

Osteo Arthritis | Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery

Osteo Arthritis research study

What is the primary objective of this study?

This study aims to assess the safety of using continuous regional anesthesia for post-operative analgesia during septic limb orthopedic surgery. The study hypothesis is that continuous regional anesthesia would not induce septic complication in the operated limb and could improve post-operative recovery.

Who is eligible to participate?

Inclusion Criteria: - Osteo arthritis or cellulitis requiring surgical intervention - anatomical possibility of regional anesthesia - age >18 ans - written informed consent Exclusion Criteria: - loco-regional anesthesia impossibility (puncture zone infection, local anesthesics allergie, amiodarone or mexilétine treatment, neurologic deficit for exemple) - patient under tutelle or curatelle - pregnant or beast feeding woman

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Osteo Arthritis

Cellulitis

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:Systemic analgesia + Continuous regional anesthesiaSystemic analgesia + Continuous regional anesthesia, peri neural for the 2 to 4 first days post-operative

Drug:Systemic analgesiaSystemic analgesia as usual

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Continuous regional anesthesia

Systemic analgesia

Study Status

Unknown status

Start Date: October 2013

Completed Date: November 2015

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Septic complication in the operated limb

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: University Hospital, Strasbourg, France

Collaborator:

More information:https://clinicaltrials.gov/show/NCT01947660

Discuss Cellulitis